Figure 1: Efficacy of perampanel versus placebo in patients with PGTC seizures. (a) 50% responder rate; and (b) change in seizure
frequency
per 28 days [reprinted with permission from American Academy of Neurology © 2015].23.
PGTC, primary generalised tonic-clonic.
Figure 1: Efficacy of perampanel versus placebo in patients with PGTC seizures. (a) 50% responder rate; and (b) change in seizure
frequency
per 28 days [reprinted with permission from American Academy of Neurology © 2015].23.
PGTC, primary generalised tonic-clonic.